Clinical Trials Directory

Trials / Unknown

UnknownNCT05202899

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Guangzhou General Hospital of Guangzhou Military Command · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Effect of sugammadex for reversal of rocuronium-induced neuromuscular block on Perioperative Management of awake Craniotomy

Conditions

Interventions

TypeNameDescription
DRUGsugammadexThe use of sugammadex

Timeline

Start date
2020-09-01
Primary completion
2022-02-28
Completion
2022-05-31
First posted
2022-01-24
Last updated
2022-03-09

Locations

1 site across 1 country: China

Regulatory

Source: ClinicalTrials.gov record NCT05202899. Inclusion in this directory is not an endorsement.

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniot (NCT05202899) · Clinical Trials Directory